cbcvebase.
CVE-2026-1029
published 2026-09-18

CVE-2026-1029: IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability…

PriorityP426medium5.4CVSS 3.1
AVNACLPRLUIRSCCLILAN
EPSS
0.16%
5.0th percentile
IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Affected

6 ranges
VendorProductVersion rangeFixed in
ibmcommon_licensing——
ibmcommon_licensing——
ibmcommon_licensing——
ibmcommon_licensing——
ibmcommon_licensing——
ibmcommon_licensing——
Stop checking back — get the weekly exploitation signal.

Every Monday: what got weaponized or added to CISA KEV in the last seven days — each CVE cross-linked to its PoC, Nuclei template, and detection rule. Free, one email a week, unsubscribe in one click.